Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ABBVIE Latest News

FEB 05, 2016 - Wall Street Journal

A Must Read - Share

J&J, AbbVie Shares Drop on Potential Drug Competition

Shares of AbbVie and Johnson & Johnson took a hit Friday after FDA briefing documents hinted a cheaper competitor for the drug companies’ blockbuster anti-inflammatory treatments could be headed to market soon.

Tags: J&J, AbbVie Shares Drop on Potential Drug Competition,  Abbvie Latest News

JAN 29, 2016 - Zacks Investment Research

A Must Read - Share

JAN 29, 2016 - Investors Business Daily

A Must Read - Share

AbbVie Reports Mixed Q4 As Merck Launches Rival HCV Treatment

Big pharma AbbVie delivered a mixed Q4 earnings report and affirmed its guidance early Friday, but the stock fell as the company faced new competition on the hepatitis C front from Merck.

Tags: AbbVie Reports Mixed Q4 As Merck Launches Rival HCV Treatment,  Abbvie Latest News

JAN 29, 2016 - ABC News

A Must Read - Share

AbbVie Cuts Costs, Turns Profit That Meets 4Q Expectations

Soaring U.S. sales of the blockbuster anti-inflammatory drug Humira and lower expenses helped AbbVie turn a $1.52-billion, fourth-quarter profit and match Wall Street's earnings expectations

Tags: AbbVie Cuts Costs, Turns Profit That Meets 4Q Expectations,  Abbvie Latest News

JAN 29, 2016 - St. Louis Post-Dispatch

A Must Read - Share

AbbVie cuts costs, turns profit that meets 4Q expectations

NORTH CHICAGO, Ill. (AP) — Soaring U.S. sales of the blockbuster anti-inflammatory drug Humira helped AbbVie post a profit of $1.52-billion for the fourth quarter and match Wall Street's earni…

Tags: AbbVie cuts costs, turns profit that meets 4Q expectations,  Abbvie Latest News